Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and ...
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain cancer model that closely mimics human glioblastoma Provides …